Orange Book product · Generic (ANDA)
CHLOROTHIAZIDE-RESERPINE
CHLOROTHIAZIDE; RESERPINE
At a glance
May 06, 1982
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 06, 1982
44 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
CHLOROTHIAZIDE; RESERPINE
Strength
250MG;0.125MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 087744
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CHLOROTHIAZIDE; RESERPINE
- 1987DIUPRES-250Brand (NDA)
NDA 011635 · MERCK
- 1983CHLOROTHIAZIDE AND RESERPINEGeneric (ANDA)
ANDA 088557 · HIKMA
- 1983CHLOROTHIAZIDE AND RESERPINEGeneric (ANDA)
ANDA 088365 · HIKMA
- 1983CHLOROTHIAZIDE W/ RESERPINEGeneric (ANDA)
ANDA 088151 · WATSON LABS
- 1982CHLOROTHIAZIDE-RESERPINEGeneric (ANDA)
ANDA 087745 · PHARMOBEDIENT
- —CHLOROTHIAZIDE W/ RESERPINEGeneric (ANDA)
ANDA 084853 · WATSON LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
